Instil Bio Inc. (TIL)
undefined
undefined%
At close: undefined
21.97
0.14%
After-hours Dec 13, 2024, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19
Net Income -156.09M -223.18M -156.79M -37.74M -6.52M
Depreciation & Amortization 4.76M 5.99M 2.75M 256.00K 20.00K
Stock-Based Compensation 18.17M 30.44M 26.20M 1.71M 293.00K
Other Working Capital -7.89M -7.76M 499.00K 2.53M 57.00K
Other Non-Cash Items 59.02M 16.15M 636.00K 5.33M 550.00K
Deferred Income Tax 1.13M - 710.00K -643.00K -
Change in Working Capital -9.02M -9.57M 4.36M 1.48M 366.00K
Operating Cash Flow -82.03M -180.16M -122.14M -29.62M -5.29M
Capital Expenditures -20.66M -84.59M -57.83M -50.82M -760.00K
Acquisitions - 1.17M - -306.00K -
Purchase of Investments -301.47M -666.22M -1.11B - -
Sales Maturities Of Investments 361.70M 865.35M 691.00M - -
Other Investing Acitivies 1.56M -1.17M - - -550.00K
Investing Cash Flow 41.13M 114.54M -474.40M -51.12M -760.00K
Debt Repayment 8.08M 70.34M - - -
Common Stock Repurchased - - - - -
Dividend Paid - - - - -
Other Financial Acitivies - 1.55M 54.15M 313.05M 14.95M
Financial Cash Flow 8.08M 71.89M 393.16M 313.05M 14.95M
Net Cash Flow -33.02M 5.63M -203.67M 232.87M 8.89M
Free Cash Flow -102.69M -264.75M -179.97M -80.43M -6.05M